TB-500 · 10mg
Research peptideThymosin β4 fragment · systemic repair, flexibility and antifibrosis
Overview
What has it been researched for?
- Repairs tendon, ligament and muscle Main focusEarly evidence
- Flexibility and less scarringEarly evidence
- Protects the heartEarly evidence
- Closes wounds and ulcersEarly evidence
- Denser hair, less sheddingEarly evidence
- Protects the retina and the eyeEarly evidence
Research protocols
The SBL research protocol and what the literature reports. Not medical advice.
SBL research protocol · no established clinical regimen in people
- Dose
- 1 mg
- Frequency
- 2×/semana
- Duration
- 8 weeks
- Route
- Subcutaneous
- Evidence level
- Preclinical
Tools
Evidence and studies
See studies →Protocols
Research protocols
SBL research protocol · no established clinical regimen in people
Research use, with no established clinical regimen in people.
- Dose
- 1 mg
- Frequency
- 2×/semana
- Timing
- cualquier hora
- Duration
- 8 weeks
- Break
- 4 weeks
- Route
- Subcutaneous
- Evidence level
- Preclinical
Example dose
30-unit U-100 insulin syringe · Starting dose of its protocol, with 2 ml of water in the 10 mg vial.
What it pairs with
Preparation and dosing
Quick reference
Preparation
- Diluent
- Bacteriostatic water
Evidence
Each effect with its evidence level and, where available, its source.
- Repairs tendon, ligament and musclePreclinicalSee study · 2026
- Flexibility and less scarringPreclinicalSee study · 2022
- Protects the heartPreclinicalSee study · 2004
- Closes wounds and ulcersExtrapolatedSee study · 2010
- Denser hair, less sheddingPreclinicalSee study · 2004
- Protects the retina and the eyeExtrapolatedSee study · 2022
The science
Mechanisms, studies and references
Thymosin β4 fragment
Safety
It makes sense if you want
- General body recovery
- Skin healing & regeneration
- Recover from an injury (tendon, joint)
It does not make sense if
- Active cancer or oncology treatment in the last 5 years
- Pregnancy or breastfeeding
Talk to your doctor first if this applies (5)
- Anticoagulants (warfarin, rivaroxaban, etc.)
- Autoimmune disease
- Cardiovascular disease
- Immunosuppressants
- Organ or bone-marrow transplant
The certificate of analysis (CoA) certifies the identity and purity of the batch. It does not certify safety of use.
Verify your batch →For research use only (RUO). This consult is educational and does not replace your doctor.
Questions
Frequently asked questions
What is it reconstituted with, and how much?
With bacteriostatic water: 2 ml into the 10 mg vial, giving 5 mg/ml.
What is the starting dose of the research protocol?
1 mg, 2×/semana. This is the SBL research protocol, with no established clinical regimen in people.
How long is the cycle, and how long does a vial last?
8 weeks ON / 4 weeks OFF. At the starting dose, the 10 mg vial lasts ~5 sem.
Which route is used in research?
Subcutaneous.
When does it make no sense?
It makes no sense with: Active cancer or oncology treatment in the last 5 years, Pregnancy or breastfeeding. Details in the Safety tab.
How do I check my batch?
With the code on the vial, in the verifier. The CoA certifies the identity and purity of the batch, not safety of use.
For research use only (RUO). This consult is educational and does not replace your doctor.